338
T. Cablewski, C. L. Francis, and A. J. Liepa
7.54–7.46 (2H, m, ArH), 4.00 (2H, m, NCH2), 3.75 (2H, m,
NCH2), 1.79 (6H, m, CH2CH2CH2). δC 157.5, 145.3, 140.2,
131.27, 131.24, 130.3, 128.4, 128.2, 125.7, 125.2, 116.5, 110.3,
49.9, 49.4, 26.0, 25.3, 23.7. m/z (EI) 372 (100%, M+•), 262 (8),
198 (72), 140 (75).
1,1-Dioxo-7-methoxy-3-piperidin-1-yl-1λ6-[1,4,2,6]
dithiadiazino[2,3-a]benzimidazole 3n and
1,1-Dioxo-8-methoxy-3-piperidin-1-yl-1λ6-[1,4,2,6]
dithiadiazino[2,3-a]benzimidazole 3o
The precipitate (a mixture of 3n and 3o, 36% yield) was puri-
fied by radial chromatography. The organic layer of the mother
liquor (from the original precipitation) was dried and evapo-
rated and the residue was also purified by radial chromatography.
In each procedure, the mobile phase used was 33–50% ethyl
acetate in petroleum spirit. Combination of appropriate frac-
tions from both procedures afforded the following. (i) The title
compound 3n (11%), recrystallized from ethanol; white nee-
dles, mp 185–186◦C. (Found: C 47.9, H 4.6, N 16.2; M+•
352.0651. C14H16N4O3S2 requires C 47.7, H 4.6, N 15.9%;
M+• 352.0658). δH (400 MHz) 7.60 (1H, d, J 9, ArH), 7.47
(1H, d, J 2.5, ArH), 7.01 (1H, dd, J 9, 2.5, ArH), 3.99 (2H,
m, NCH2), 3.90 (3H, s, OMe), 3.75 (2H, m, NCH2), 1.79 (6H,
m, CH2CH2CH2). δC 158.6, 158.0, 138.7, 135.4, 132.2, 119.7,
114.8, 96.3, 56.0, 49.9, 49.5, 26.0, 25.4, 23.8. m/z (EI) 352 (75%,
7-Chloro-3-dimethylamino-1,1-dioxo-1λ6-[1,4,2,6]
dithiadiazino[2,3-a]benzimidazole 3j and
8-Chloro-3-dimethylamino-1,1-dioxo-1λ6-[1,4,2,6]
dithiadiazino[2,3-a]benzimidazole 3k
The precipitate (a mixture of 3j and 3k, 46% yield) was puri-
fied by radial chromatography. The organic layer of the mother
liquor (from the original precipitation) was dried and evapo-
rated and the residue was also purified by radial chromatography.
In each procedure, the mobile phase used was 50–100% ethyl
acetate in petroleum spirit and then 0–20% ethyl acetate in
dichloromethane. Combination of appropriate fractions from
both procedures afforded the following compounds. (i) The
title compound 3j (19%), recrystallized from methanol; white
needles, mp 229–230◦C. (Found: C 38.1, H 2.9, N 17.6; M+•
315.9809. C10H9ClN4O2S2 requires C 37.9, H 2.9, N 17.7%;
M+• 315.9850). δH (400 MHz) 7.92 (1H, d, J 8.8, ArH), 7.72
(1H, d, J 1.9, ArH), 7.39 (1H, dd, J 8.8, 1.9, ArH), 3.42 (3H,
s, NCH3), 3.38 (3H, s, NCH3). δC 160.2, 142.4, 142.1, 130.6,
129.7, 125.5, 119.3, 114.1, 41.1, 39.5. m/z(EI)318/316(22/53%,
M
+•), 242 (8), 178 (100). (ii) A mixture of 3n and 3o (38%).
(iii) The title compound 3o (13%), recrystallized from ethanol;
colourless needles, mp 184.5–185◦C. (Found: C 47.6, H 4.5,
N 16.0; M+• 352.0655. C14H16N4O3S2 requires C 47.7, H 4.6,
N 15.9%; M+• 352.0658). δH (400 MHz) 7.87 (1H, d, J 9, ArH),
7.19 (1H, d, J 2.5, ArH), 7.04 (1H, dd, J 9, 2.5, ArH), 3.98 (2H,
m, NCH2), 3.87 (3H, s, OMe), 3.74 (2H, m, NCH2), 1.79 (6H,
m, CH2CH2CH2). δC 158.3, 157.8, 142.0, 141.0, 125.7, 114.6,
113.7, 101.6, 55.8, 49.9, 49.5, 26.0, 25.4, 23.8. m/z (EI) 340
(80%, M+•), 242 (7), 178 (100).
M
+•), 184/182 (16/40), 149 (100). (ii) A mixture of 3j and 3k
(16%). (iii) The title compound 3k (18%), recrystallized from
methanol; white needles, mp 237–238◦C. (Found: C 37.9, H
2.9, N 17.7; M+• 315.9813. C10H9ClN4O2S2 requires C 37.9,
H 2.9, N 17.7%; M+• 315.9850). δH (400 MHz) 8.03 (1H, d,
J 1.8, ArH), 7.64 (1H, d, J 8.4, ArH), 7.37 (1H, dd, J 8.4, 1.8,
ArH), 3.42 (3H, s, NCH3), 3.38 (3H, s, NCH3). δC ([D6]DMSO)
159.1, 143.2, 139.8, 130.9, 129.3, 125.3, 120.8, 112.2, 40.9, 39.8.
m/z (EI) 318/316 (42/100%, M+•), 248/246 (10/24), 184/182
(26/67), 147 (45). (iv)The starting 2-mercaptobenzimidazole 2d
(11%).
5-Substituted-3-mercapto[1,2,4]triazoles 5b–f
5-Isopropyl-3-mercapto[1,2,4]triazole 5b,[18] 5-tert-butyl-3-
mercapto[1,2,4]triazole 5c,[19] 3-mercapto-5-phenyl[1,2,4]
triazole 5d,[20,21] 5-(4-tert-butylphenyl)-3-mercapto[1,2,4]
triazole 5e,[22] and 3-mercapto-5-(4-pyridyl)[1,2,4]triazole
5f[21] werepreparedbymodificationofaliteratureprocedure.[21]
Thus, a mixture of the appropriate hydrazide (30 mmol) and
ammonium thiocyanate (45 mmol) in a conical flask was melted
at 170–180◦C on a hotplate. Heating was continued until bub-
bling ceased and the mixture began to solidify (60–90 min). The
mixture was removed from the hotplate and allowed to cool
slightly. Water (15–20 mL) was added slowly with stirring and
the mixture briefly brought to the boil.The mixture was cooled to
room temperature then cooled further in ice and filtered.The col-
lected solid was dissolved in aqueous sodium carbonate solution
(10%) with stirring and gentle heating. Any insoluble material
was filtered off and the filtrate slowly acidified with concen-
trated hydrochloric acid. The precipitated solid was collected
by filtration, washed on the filter with water and then dried to
provide the title compounds, which were used without further
purification.
3-Diethylamino-1,1-dioxo-7-methoxy-1λ6-[1,4,2,6]
dithiadiazino[2,3-a]benzimidazole 3l and
3-Diethylamino-1,1-dioxo-8-methoxy-1λ6-[1,4,2,6]
dithiadiazino[2,3-a]benzimidazole 3m
No precipitate formed. The organic layer was dried and evap-
orated and the residue was purified by radial chromatography.
Elution with 33–50% ethyl acetate in petroleum spirit afforded
three fractions. (i) The title compound 3l (11%), recrystallized
from ethanol; small, white crystals, mp 145.5–146◦C. (Found:
C 45.9, H 4.8, N 16.4; M+• 340.0660. C13H16N4O3S2 requires
C 45.9, H 4.7, N 16.5%; M+• 340.0658). δH (400 MHz) 7.60
(1H, d, J 9, ArH), 7.47 (1H, d, J 2.5, ArH), 7.00 (1H, dd, J 9,
2.5, ArH), 3.90 (3H, s, OMe), 3.80 (2H, q, J 7, NCH2), 3.66
(2H, q, J 7, NCH2), 1.41 (3H, t, J 7, CH3), 1.34 (3H, t, J 7,
CH3). δC 159.3, 158.0, 138.7, 135.4, 132.1, 119.7, 114.8, 96.3,
56.0, 46.7, 45.7, 13.2, 12.4. m/z (EI) 340 (72%, M+•), 242 (11),
178 (100). (ii) A mixture of 3l and 3m (5%). (iii) The title
compound 3m (13%), recrystallized from ethanol; colourless
prisms, mp 174.5–175.5◦C. (Found: C 45.9, H 4.7, N 16.4;
5b: δH ([D6]DMSO) 13.14 (1H, br s, NH/SH), 13.07 (1H, br
s, SH/NH), 2.83 (1H, sep, J 7, CH), 1.16 (6H, d, J 7, CMe2). δC
([D6]DMSO) 166.6, 157.5, 26.1, 20.5. m/z (APCI) 142 (100%,
M − H•).
5c: δH ([D6]DMSO) 13.14 (2H, br s, NH + SH), 1.21 (9H, s,
C(CH3)3). δC ([D6]DMSO) 166.8, 159.9, 31.8, 28.3. m/z (APCI)
156 (100%, M − H•), 124 (43, M − SH•).
M
M
+• 340.0666. C13H16N4O3S2 requires C 45.9, H 4.7, N 16.5%;
+• 340.0658). δH (400 MHz) 7.88 (1H, d, J 9, ArH), 7.19 (1H,
d, J 2.5, ArH), 7.04 (1H, dd, J 9, 2.5, ArH), 3.87 (3H, s, OMe),
3.80 (2H, q, J 7, NCH2), 3.66 (2H, q, J 7, NCH2), 1.41 (3H, t,
J 7, CH3), 1.34 (3H, t, J 7, CH3). δC 158.9, 157.8, 142.0, 141.0,
125.7, 114.6, 113.7, 101.6, 55.8, 46.7, 45.6, 13.2, 12.4. m/z (EI)
340 (92%, M+•), 242 (10), 178 (100).
5d: δH ([D6]DMSO) 13.82 (1H, br s, NH/SH), 13.66 (1H, br
s, SH/NH), 7.92–7.86 (2H, m, ArH), 7.52–7.46 (3H, m, ArH).
δC ([D6]DMSO) 167.5, 150.6, 131.0, 129.5, 126.1, 125.9.
5e: δH ([D6]DMSO) 13.76 (1H, br s, NH/SH), 13.60 (1H, br
s, SH/NH), 7.82 (2H, d, J 8.4,ArH), 7.50 (2H, d, J 8.9,ArH), 1.27